Elekta signs sales and marketing agreement with Toshiba in Japan

Elekta K.K., a wholly owned subsidiary of Elekta AB, has entered into a sales and marketing agreement with Toshiba Medical Systems Corporation in Japan.

Stockholm Sweden — Thursday, December 9, 2010

According to the agreement, Toshiba Medical Systems Corporation will sell and market Elekta’s products and clinical solutions in the Japanese radiotherapy market. This will ensure that patients there get unparalleled cancer care through Elekta’s leading products and services. 

Tim Rooney, President and Managing Director of Elekta K.K. says: “I am very pleased that we have entered into this important agreement with Toshiba Medical Systems Corporation. As a world leader in diagnostic imaging systems, coupled with its comprehensive sales network of 70 offices in Japan and extensive experience in the radiotherapy market, Toshiba Medical Systems Corporation is the perfect long-term partner for Elekta K.K. This collaboration will enable both companies to extend and enhance their commitment to providing world class, cutting-edge solutions to the Japanese radiotherapy market.” 

Yasuo Nobuta, Vice President of Toshiba Medical Systems Corporation, says the company is very pleased with the agreement with Elekta K.K. 

“All of us at Toshiba Medical Systems Corporation are very excited about this agreement with Elekta K.K. as it will allow us to offer the most advanced forms of radiotherapy treatment to our customers and their patients in Japan” says Yasuo Nobuta. 

Elekta K.K will manage the overall relationship with Toshiba Medical Systems Corporation through its sales, marketing and service organizations. Elekta K.K. expects the agreement to increase sales opportunities in Japan. 

Growing need for cancer management resources

“This agreement is important in a country where cancer has become the leading cause of death,” Rooney says. “By opening up an additional sales channel for our linear accelerators and software products, we anticipate more people will get the quality of treatment they need.” 

According to statistics compiled by the Japanese Ministry of Health, Labour and Welfare, 336,290 people died of cancer in 2007; the disease was responsible for one out of every three deaths.

 

###

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb.

Visit Elekta - www.elekta.com

Press Releases

For further information, please contact

Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37
Email: stina.thorman@elekta.com
Time zone: CET: Central European

Michelle Lee, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447
Email: michelle.lee@elekta.com
Time zone: EDT: Eastern Daylight Time